the effect of group cognitive-behaviour therapy in combination with pharmacotherapy on mania and depression symptoms and awareness of warming signs of relapse in patients with bipolar disorder

objective:this research has been done according to the cognitivebehavioral theories and biochemical model in order to evaluate the efficiency of group cognitive-behavior therapy in combination with pharmacotherapy on mania and depression symptoms and awareness of warning signs of relapse in patients with bipolar disorder. methods:in this study with the experimental pretest- posttest- follow up plan , 30 women suffering from bipolar disorder, randomly assigned to receive either the group cognitive-behavior therapy (experimental group, n=15) or usual treatment (control group, n=15);and were follow-up for a six months. patients in both groups were prescribed standard pharmacotherapy. first all subjects were put to a pretest in equal conditions with measures of scale 2 and 9 of mmpi test, and warning signs checklist. then the experimental group received group cognitive-behavior therapy for 8 sessions in addition to their medication therapy. the control group only received medicine. at the end of the experiment, all subjects were tested under equal conditions. after completion of the treatment process, the subjects of both groups were supervised for 6 months. the findings of the study were analyzed by the statistical method of multi-variable analysis of variance with repetitive measurements. results:the findings showed that the group cognitive-behavior therapy had been significantly more efficient in reduction of mania symptoms {p=0/03} and increment of awareness of warning signs of relapse {p=0/00} in comparison with control group; but there is no significantly differences in depression symptoms between two groups. conclusion: the findings of this study suggest the beneficial effect of group cognitive-behavior therapy in reducing of mania symptoms and increment of awareness of warning signs of relapse. therefore, it can be used as a complementary treatment by clinicians